Nick Mark MD Profile picture
Feb 12 34 tweets 15 min read
In confronting COVID misinformation I’ve mostly focused on inpatient treatment (this is my area of experience).

Recently I saw the FLCCC Long COVID “protocol” & oh boy is this some crazy non-evidence based prescriptions: HIV meds, steroids, diuretics, & of course ivermectin…
1/
First off, Long COVID is definitely “real” & can be severe.

Many studies have found persistent changes in immune cell phenotype & function, months after COVID infection.

Many great docs (@WesElyMD & others) are actively researching long COVID to improve our understanding.
2/
What concerns me is FLCC presenting “protocols” as proven treatments for long COVID.

Throwing 20 medications (9 are prescription 🟥) at a problem with minimal (or no) evidence is irresponsible.
nature.com/articles/s4159…

As we will see, this is both unethical & likely harmful.
3/
What's the evidence for ivermectin in Long COVID? Basically nothing!

Despite ~200 studies on Long COVID, there are ZERO registered studies of IVM in long COVID.

Even among 86 IVM studies, the only thing even close is a small study looking at anosmia.

Not much evidence...
4/
What evidence do ivermectin proponents cite?

Kory references ONE uncontrolled study (really just an abstract;👀 below), where they gave n=33 people ivermectin at increasing doses & eventually they got better. Preprint posted in July 2020. Still unpublished.
Not compelling...
5/
Not only are there *ZERO* published RCTs of ivermectin in long COVID (or any in progress), there isn't even *ONE* controlled study.
The 'evidence base' for ivermectin in long COVID consists of one sketchy unpublished uncontrolled pre-print abstract of n=33 pts.
Thats it.
6/
On to the other aspects of the “protocol”:

Chronic steroids in COVID is a complex question. For outpatients who were never hypoxic there’s NO evidence for benefit (and quite possibly harm) with steroids.
7/
What’s the evidence for chronic steroids in post COVID outpatients?
Again basically nothing.

One RCT was done. It’s still unpublished so we don’t know if it helped or made things worse.

A few observational studies with contradictory results.

No good evidence for steroids
8/
This is not to say they is no role for steroids post-COVID. There *may* be a role for a longer steroid course in select patients (e.g. organizing pneumonia or fibrosis on chest CT) but no such subtlety is present in the FLCCC protocol.

Just 3 weeks of steroids for everyone!
9/
On to the next Rx: low dose naltrexone

There is a *theoretical* argument that naltrexone inhibits ERK1/2 signaling, which downregulates inflammation... again there is no clinical data that this is actually beneficial.

No studies on naltrexone whatsoever in long COVID.
10/
There is ONE study that actually looked at naltrexone in acute COVID19: SINK-COVID19 (NCT0436598)
clinicaltrials.gov/ct2/show/resul…

It randomized n=9 people to naltrexone vs n=9 to placebo.
It found no difference in ANY outcome.
It's the *ONLY* public data about naltrexone in COVID.
11/
On to the "second line therapies"

Fluvoxamine *IS* indeed a promising therapy for COVID. It's been shown to reduce hospitalizations/ED visits among outpatients who are newly diagnosed with COVID.


But does that mean it works for long COVID too?
12/
There are ZERO RCTs of fluvoxamine in post-COVID. There are also ZERO interventional or observational studies of fluvoxamine in long-COVID.

There is literally no evidence that fluvoxamine reduces symptom severity or duration (or *anything*) in long covid.
13/
So far this "long COVID protocol" is 0/4 for actual evidence among prescription meds.

What about #5: atorvastatin?

Statins probably DO reduce inflammation & reduce (long term) mortality in most people but the evidence in COVID is surprisingly weak.
hopkinsmedicine.org/news/newsroom/…

14/
There actually ARE well designed studies trying to figure out *IF* statins help in long COVID.

STRONGER an open label n=400 RCT of atorva vs SOC
clinicaltrials.gov/ct2/show/NCT04…

and

HEAL-COVID an n=2631 RCT of atorva vs SOC
clinicaltrials.gov/ct2/show/NCT04…

(Aside: both are great acronyms)
15/
The fact that there are studies ongoing means that there is equipoise about whether these statins work or not.

I'm excited to see the results of STRONGER & HEAL-COVID but I'm not holding my breath. Until results are published there is NO evidence for statins in long COVID.
16/
On to the next & oddest med in this protocol: Maraviroc.

Maravaric is a CCR5 chemokine receptor antagonist, used to treat HIV infection by blocking its entry into CCR5 expressing cells.

Maraviroc isn't generic & it's expensive: typically over $2000 for the 300mg BID dose.

17/
As with everything else in the this protocol, there are exactly ZERO studies of Maravaric in long COVID.

No RCTs. No interventional studies. No observational studies. Nothing. Nada.

Pay $2k/month for 2 months (which insurance definitely won't cover) based on no evidence.
18/
Interestingly, there were 2 early stage trials of maraviroc in severe COVID, w/ the hypothesis that blocking CCR5 would reduce neutrophil infiltrates in 🫁 preventing/mitigating ARDS

This is a nice *idea* for an inpatient clinical trial. NOT an outpatient treatment protocol
19/
But here's where it gets even sketchier...

The protocol says consider "getting an InCellDx test to assess long hauler index"

Huh?

Looks like another COVID grifter has entered the scene.
motherjones.com/politics/2022/…
20/
Basically, InCellDx used a 14 cytokine panel to do a tiny study in 121 post-COVID pts vs 29 health controls

They found tiny cytokine changes but via the magic of ML created an overfit unvalidated random forest model to spit out "long haul covid index"
frontiersin.org/articles/10.33…
21/
InCellDx's science is 'meh' but their marketing is top notch!
InCellDx turned their cytokine test & "long haul COVID index" into quite the product.
They created a COVID support group "COVID long haulers" to push the test.
They also appear to have partnered w/ FLCCC & others.
22/
Never mind the inconvenient question: "WHY do this expensive cytokine test for long COVID?"

What clinical implications does that test have? There's absolutely no evidence to start or stop *any* therapy based on the result.

At best this is a research tool. At worst a scam.
23/
Another point about bad data science:
The group used a technique called SMOTE (synthetic minority over sampling technique). I’ve used this before. It’s great for rare events but it’s super weird to use it to oversample healthy controls. Why not get more volunteers?

A big 🚩
Talking to people who have been through it:
After the $360 test, InCellDx charges $200 for a video consultation, then $300 for more tests.

Then a referral to a FLCCC approved doc ($200+) followed by $2k/month for maraviroc.

Seems like InCellDx is cashing in on long COVID.
24/
As for another prescription included in this protocol: high dose diuretics (spironolactone).

Starting spironolactone at higher than recommended dose *without checking electrolytes* is dangerous & potentially malpractice.

I’ve written about this previously👇
25/
Last but not least: Montelukast.

As a pulmonologist, I know this med very well & there are reasons to think it *could* help alleviate dyspnea after COVID pneumonia.

But what’s the actual evidence for montelukast in long COVID?

Once again not very much…
26/
There actually are ongoing clinical trials of montelukast in long COVID, such as the well named E-SPERANZA study in 🇪🇸
clinicaltrials.gov/ct2/show/NCT04…

This trial is predicated upon a 13 person uncontrolled pilot study. That n=13 study is the sum total of evidence for Montelukast btw
27/
One article proposes using montelukast because of “the lack of effective therapy, chemo prevention, & vaccination.”

Oh wait we have all of those things now. Maybe we don’t need montelukast…?

This raises an important point. The best way to prevent long COVID is vaccination!
28/
Speaking of effective: there is evidence that vaccination can improve long COVID symptoms!

In an observational study of n=163 people with severe long COVID 8 months after infection, 95% reported improved/stable symptoms 1 month following vaccination
pubmed.ncbi.nlm.nih.gov/34029484/
29/
If the FLCCC protocol is what NOT to do, how *should* we treat long COVID?

UpToDate has a pretty good open access article:
uptodate.com/contents/covid…

27/
Instead of a one size fits all kitchen sink approach involving 20+ meds (each with potential side effects), it recommends a stepwise approach based on symptoms, timing, & severity.

There are actual proven therapies for post ICU syndrome & sequelae of critical illness.
27/
If you are suffering from long COVID, there are reputable doctors who can help. There are centers of excellence (such as the @CIBScenter) & clinical trials you can enroll in (see the 🧵 above).

Don’t get taken advantage of by discredited scam artists pushing “protocols”.
28/
Summary:
-the “I-RECOVER protocol” of 20 meds is dangerous nonsense. None of these interventions is based on robust clinical trials.
-taking an unproven combination of meds could make you feel worse not better.
-don’t get conned into paying these quacks for this “protocol”

fin/

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Nick Mark MD

Nick Mark MD Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @nickmmark

Feb 2
Do you want to improve working conditions for residents/fellows in WA?

The WA legislature is voting on HR1764 which would allow interest arbitration in collective bargaining.

This would go a long way towards correcting the power imbalance between administration & residents.
1/
Under the current system of negotiation, residents can *request* certain changes: safe working conditions, sufficient PPE, hazard/overtime pay, etc.

Administrators (who are often non-clinical) just say NOPE.

Because residents can’t/won’t strike they don’t have much leverage.
2/
When we formed the UWHA/@RFPU_NW resident union we spent YEARS fighting with administrators over these issues.

Ultimately we got lucky. Pressure from the city council & media attention helped us break the logjam.

There ought to be a better way.

3/
dailyuw.com/news/uw-medica…
Read 8 tweets
Feb 1
Instead of proposals to cap RN pay I’d love to see legislation that:
1️⃣mandates safe RN staffing ratios nationwide
2️⃣enacts a “50 state medical license” w/ straightforward reciprocity
3️⃣imposes limits on executive compensation for any hospital/org that bills CMS
For those doubting these reforms are possible. A couple points:

There already is a federal law calling for “adequate numbers of licensed RNs” 42CFR 482.23(b) The issue is that this is too vague.

15 states have passed laws that go further. CA & MA explicitly stipulate RN ratios
The CA law, enacted in 2004, mandates 1 RN to 5 med/surg patients & 1:2 for ICU patients.

After implementation RNs cared for one fewer patient on average. There was a decrease in hospital mortality & increased RN job satisfaction. ncbi.nlm.nih.gov/pmc/articles/P…
Read 6 tweets
Jan 21
The ivermectin crazies are now recommending hydroxychloroquine too.

Their “protocol” includes a dangerously high dose of diuretics & recommends high dose steroids in people not on supplemental O2.

This has crossed the line from (mostly) harmless nonsense to actual harm.
Supporting Evidence:

A 2021 Cochrane meta-analysis (the 🥇standard) concluded that HCQ “has little or no effect on the risk of death and probably no effect on progression to mechanical ventilation. Adverse events are tripled compared to placebo…”

cochranelibrary.com/content?templa…
A more recent meta-analysis in @NatureComms that included unpublished studies went further, concluding “that treatment with hydroxychloroquine is associated with increased mortality in COVID-19 patients”

nature.com/articles/s4146…
Read 9 tweets
Jan 20
Just 3️⃣simple acts of compassion can go a long way

Important RCT just published in @TheLancet shows that a family support strategy consisting of 3 extra family meetings can substantially reduce family grief 6mo after the death of a loved one in the ICU
thelancet.com/journals/lance…
1/
Pre-pandemic, ICU mortality was often ~20%

In the US, 30-60% of ICU deaths were preceded by a decision to withdraw life support

We are experts at providing comfort focused care for patients but in many cases, families feel grief months afterwards

What can we do about this?
2/ ImageImage
The COSMIC RCT studied this.

The intervention was 3 family meetings held following a decision to withdraw life support:

1️⃣family conference to prepare relatives for the imminent death
2️⃣ICU-room visit to provide support
3️⃣meeting after death to offer condolences & closure

3/ ImageImage
Read 7 tweets
Jan 17
To those who are unvaccinated because of worries about “unproven mRNA technology” you know you can get:
- the J&J vaccine (🇺🇸)
- the Oxford-AZ vaccine (🇬🇧&🇪🇺)

Both can prevent hospitalization or death from COVID. Neither are mRNA vaccines. So why not get vaxxed today?
To those worried about blood clots after J&J, as of April 2021:
-there were 15 cases of TTS
-out of 8 million J&J doses

That’s a risk of less than 1 in 500,000. cdc.gov/mmwr/volumes/7…

The risk of getting struck by lightning is higher than that! cdc.gov/disasters/ligh…
The vaccine efficacy (VE) of the J&J vaccine *is* slightly less than the mRNA alternatives: 68-71% VE to prevent hospitalization (compared to ~90% for mRNA vaccines). That’s still much much better than being Unvaxxed.

(N.B. this is pre-omicron data)
cdc.gov/mmwr/volumes/7…
Read 5 tweets
Jan 16
Updated WHO severe COVID treatment guidelines bit.ly/3rhGgKW

Recommended
🟢Steroid (#Dexamethasone)
🟢IL6 blocker (#Toci) or 🟢JAKi (#Baricitinib)
🟠±mAb in seronegative people

NOT recommended
🔴#Hydroxychloroquine
🔴#ivermectin
🔴#remdesivir

Lots to discuss, a🧵
1/
Remdesivir (RDV) is in the “We suggest no remdesivir” category.
At some level, this isn’t too surprising & is old news.
Despite initial hype, RDV never moved the needle much on patient centered outcomes (risk of mortality or requiring IMV) & many of us had stopped using it.
2/
In #ACTT1 RDV did improve outcomes on an ordinal scale, but the effect was modest. It shortened time to clinical improvement but not hospital LOS (patients stayed in the hospital longer to receive it).
RDV did NOT improve mortality or risk of IMV.
ncbi.nlm.nih.gov/pubmed/32445440
3/
Read 19 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

:(